Get the Stockscreener App
0.405
3.74%
0.0146
China Sxt Pharmaceuticals Inc stock is traded at $0.405, with a volume of 182.58K.
It is up +3.74% in the last 24 hours and down -29.57% over the past month.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
See More
Previous Close:
$0.3904
Open:
$0.4088
24h Volume:
182.58K
Relative Volume:
0.33
Market Cap:
$1.63M
Revenue:
$1.93M
Net Income/Loss:
$-3.10M
P/E Ratio:
-0.0167
EPS:
-24.3081
Net Cash Flow:
$-1.93M
1W Performance:
+5.66%
1M Performance:
-29.57%
6M Performance:
-62.15%
1Y Performance:
-78.23%
1-Day Range:
$0.40
$0.4399
1-Week Range:
$0.3721
$0.4399
52-Week Range:
$0.3711
$6.39
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
Compare SXTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
0.405 | 1.63M | 1.93M | -3.10M | -1.93M | -24.31 |
|
ZTS
Zoetis Inc
|
176.74 | 80.59B | 9.15B | 2.43B | 2.31B | 4.92 |
|
HLN
Haleon Plc Adr
|
9.72 | 44.17B | 14.26B | 1.55B | 0 | 0.3327 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.57 | 42.61B | 30.27B | 1.93B | 3.45B | 0.444 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.57 | 18.77B | 16.77B | -959.00M | 1.37B | -2.00 |
|
VTRS
Viatris Inc
|
13.22 | 15.73B | 15.05B | -883.30M | 1.89B | 1.53 |
China Sxt Pharmaceuticals Inc Stock (SXTC) Latest News
SXTC stock hits 52-week low at $0.43 amid sharp annual decline - Investing.com Australia
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.05% - MSN
SXTC stock touches 52-week low at $0.52 amid market challenges - Investing.com India
SXTC stock touches 52-week low at $0.52 amid market challenges By Investing.com - Investing.com South Africa
In the Green: China SXT Pharmaceuticals Inc (SXTC) Closes at 0.63, Up/Down 12.64 from Previous Day - The Dwinnex
SXTC’s Stock Market Adventure: -84.07% YTD Growth Amidst Volatility - The InvestChronicle
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.05% - MSN
Visteon to Announce Third Quarter 2024 Results - The Manila Times
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency - The Manila Times
China SXT Pharmaceuticals Inc’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle
SXTC’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Insider’s View: Deciphering China SXT Pharmaceuticals Inc (SXTC)’s Financial Health Through Ratios - The Dwinnex
SXTC’s Market Whiplash: -83.70% YTD Decline, -22.51% Plunge in 30 Days - The InvestChronicle
How does SXTC’s price to cash per share ratio compare in the market? - US Post News
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Significant Decline in Short Interest - Defense World
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Large Increase in Short Interest - Defense World
China SXT Pharmaceuticals (NASDAQ:SXTC) Stock Quotes, Forecast and News Summary - Benzinga
China's First Generic Version of AstraZeneca's Xigduo XR Diabetes Pill Gets Green Light - Yicai Global
SIMPLY SOLVENTLESS PROVIDES Q3 2024 GUIDANCE INCLUDING RECORD PROJECTED QUARTERLY REVENUE AND EIGHTH STRAIGHT QUARTER OF NET INCOME PROFIT, AND ANNOUNCES UPCOMING PRODUCT LAUNCHES – Company A - Financial Times
China SXT Pharmaceuticals Inc (SXTC)’s results reveal risk - US Post News
China SXT Pharmaceuticals Inc (SXTC) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
SXTC stock touches 52-week low at $0.6 amid sharp annual decline - Investing.com India
Closing Figures Unveiled: China SXT Pharmaceuticals Inc (SXTC) Drop -8.88, Closes at 0.63 - The Dwinnex
SXTC stock plunges to 52-week low of $0.75 amid market challenges - Investing.com Australia
SXTC’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Market Resilience: China SXT Pharmaceuticals Inc (SXTC) Finishes Weak at 0.94, Down -6.00 - The Dwinnex
China SXT Pharma stock hits 52-week low at $0.92 amid downturn - Investing.com India
SXTC stock hits 52-week low at $0.93 amid sharp annual decline - Investing.com India
Navigating SXTC Stock: China SXT Pharmaceuticals Inc Journey - The InvestChronicle
Did China SXT Pharmaceuticals Inc (SXTC) perform well in the last session? - US Post News
China SXT Pharmaceuticals Inc (SXTC) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Balance Sheet Insights: China SXT Pharmaceuticals Inc (SXTC)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
China SXT Pharmaceuticals Inc (SXTC) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Down 25.1% in June - Defense World
China SXT Pharmaceuticals Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - The InvestChronicle
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Market Watch Highlights: China SXT Pharmaceuticals Inc (SXTC) Ends on an Downturn Note at 1.06 - The Dwinnex
Examining China SXT Pharmaceuticals Inc (SXTC) stock is warranted - US Post News
China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment - Quantisnow
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Update - Defense World
Successful Portfolios LLC Lowers Stock Holdings in The Southern Company (NYSE:SO) - Defense World
China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split - Quantisnow
Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares ... - Quantisnow
China SXT Pharmaceuticals Inc Inc. (SXTC) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
A closer look at China SXT Pharmaceuticals Inc (SXTC) is warranted – US Post News - US Post News
Deeper Dive: Understanding China SXT Pharmaceuticals Inc (SXTC) Through its Various Ratios – DWinneX - The Dwinnex
SXTC’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
China SXT Pharmaceuticals Inc (SXTC) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Daily Market Movement: China SXT Pharmaceuticals Inc (SXTC) Sees a 0.94 Increase, Closing at 1.07 – DWinneX - The Dwinnex
12 Health Care Stocks Moving In Monday's Pre-Market SessionAkanda (NASDAQ:AKAN) - Benzinga
China Sxt Pharmaceuticals Inc Stock (SXTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.83%
1.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):